Robust eIF4B levels undermine invasive growth and immune evasion mechanisms in murine triple negative breast cancer models.
R. Smith, L. Z. D. Z. D. Diba, A. Srinivasan, R. A. Zollo, T. Ossevoort, Q. He, S. H. Colligan, M. Dolan, Y. Vedire, T. Sultana, M. Venkatesh, A. P. Arora, S. Gawlak, D. Washington, C. Brackett, , S. E. Walker
This study shows that higher eIF4B levels in murine triple negative breast cancer models are linked to less aggressive tumor growth and better patient outcomes.
bioRxiv · Sep 16, 2022 · PreprintCancer Biology